GlassScriptPhysician profile
Vincent Dien Ho
NPI 1144249871
$9,967.94
in general payments reported to CMS, 2019-2025
43 companies · $1,640 in 2025
The $1,640 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,023 · 2020: $691 · 2021: $1,092 · 2022: $1,366 · 2023: $1,886 · 2024: $2,269 · 2025: $1,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,795.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,422.37 | 2019-2025 | Farxiga, Breztri, Fasenra |
| Amgen INC. | $968.72 | 2020-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $830.33 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $737.32 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $702.10 | 2020-2025 | Jardiance, Mounjaro, Zepbound |
| Abbvie INC. | $625.00 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $587.73 | 2021-2025 | |
| Amarin Pharma, INC. | $335.20 | 2019-2023 | |
| Pfizer INC. | $275.95 | 2020-2025 | |
| Radius Health, INC. | $256.28 | 2019-2024 | Tymlos |
| Boston Scientific Corporation | $211.90 | 2021-2022 | |
| Glaxosmithkline, LLC. | $211.75 | 2020-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Nestle Healthcare Nutrition INC. | $189.36 | 2021-2023 | |
| Aimmune Therapeutics, INC. | $169.61 | 2024-2025 | Zenpep |
| Merck Sharp & Dohme LLC | $167.13 | 2019-2024 | Verquvo |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.